For Laboratory Research Use Only · Not for Human or Veterinary Use · 21+

Growth & Anabolic Research

CJC-1295

CJC-1295

The long-acting GHRH analog

$46.0025% OFF · code RESEARCH25
Third-Party TestedCOA Every VialUSA Shipped

What It Is

A GHRH analog with DAC (drug-affinity complex) modification that extends its half-life via albumin binding — studied for sustained growth-hormone-axis stimulation.

How It Works

CJC-1295 reference art
GHRH-R
Studied for binding GHRH receptors on pituitary cells to stimulate growth-hormone release.
DAC
Albumin binding is investigated for protecting the peptide from enzymatic breakdown, extending signaling.

What the Research Shows

2006 · J Clin Endocrinol Metab · Teichman et al.
Investigated GH/IGF-1 response to a long-acting GHRH analog.

Citations reference published research. For research purposes only; no therapeutic claims.

Research Focus

  • ✓Studied as a GH secretagogue
  • ✓Investigated for GH/IGF-1 pathway research
  • ✓Explored alongside ghrelin-receptor agonists

Blends Well With

Ipamorelin
$44.00
Sermorelin
$62.00
Tesamorelin
$87.00

Frequently Asked Questions

What is CJC-1295?
A GHRH analog studied as a research secretagogue.
What does the DAC modification do?
It is studied for extending half-life via albumin binding.
Is it FDA approved?
No — sold for research use only, not for human use.
Shop CJC-1295 · 25% off →

Code RESEARCH25 · applied at checkout

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. 21+. US shipping only. Charge appears as GULFPORT LOGIS.
© 2026 Choice Peptide Labs